Halberd Corp

Halberd Corp.

Biotechnology Healthcare Jackson Center, PA, United States HALB (PNK)

Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer's and Parkinson's disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.

Stock Performance (90 Days)

Data through Dec 26, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Other Biotechnology Companies

View All →

Frequently Asked Questions

Has Halberd Corp had layoffs?
No layoff events have been recorded for Halberd Corp in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
What industry is Halberd Corp in?
Halberd Corp operates in the Biotechnology industry, within the Healthcare sector.
Is Halberd Corp a publicly traded company?
Yes, Halberd Corp is publicly traded under the ticker symbol HALB on the PNK. The company has a market capitalization of approximately $0.00 billion.
Where is Halberd Corp headquartered?
Halberd Corp is headquartered in Jackson Center, PA, United States at PO Box 25, Jackson Center, PA 16133, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.